摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-{1-[2-({6-[1-(cyclopropylmethyl)-1H-pyrazol-4-yl]-1H-benzimidazol-2-yl}amino)pyridin-4-yl]ethyl}piperazin-1-yl)-3,3,3-trifluoropropan-1-one

中文名称
——
中文别名
——
英文名称
1-(4-{1-[2-({6-[1-(cyclopropylmethyl)-1H-pyrazol-4-yl]-1H-benzimidazol-2-yl}amino)pyridin-4-yl]ethyl}piperazin-1-yl)-3,3,3-trifluoropropan-1-one
英文别名
1-[4-[(1~{R})-1-[2-[[5-[1-(cyclopropylmethyl)pyrazol-4-yl]-1~{H}-benzimidazol-2-yl]amino]pyridin-4-yl]ethyl]piperazin-1-yl]-3,3,3-tris(fluoranyl)propan-1-one;1-[4-[(1R)-1-[2-[[6-[1-(cyclopropylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]pyridin-4-yl]ethyl]piperazin-1-yl]-3,3,3-trifluoropropan-1-one
1-(4-{1-[2-({6-[1-(cyclopropylmethyl)-1H-pyrazol-4-yl]-1H-benzimidazol-2-yl}amino)pyridin-4-yl]ethyl}piperazin-1-yl)-3,3,3-trifluoropropan-1-one化学式
CAS
——
化学式
C28H31F3N8O
mdl
——
分子量
552.602
InChiKey
WEFRCKPVMWDRAK-GOSISDBHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    40
  • 可旋转键数:
    8
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    95
  • 氢给体数:
    2
  • 氢受体数:
    9

反应信息

  • 作为产物:
    描述:
    3,3,3-三氟丙酸 、 6-[1-(cyclopropylmethyl)-1H-pyrazol-4-yl]-N-{4-[(1R)-1-(piperazin-1-yl)ethyl]pyridin-2-yl}-1Hbenzimidazol-2-amine hydrochloride 在 碳酸氢钠 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 以44 %的产率得到1-(4-{1-[2-({6-[1-(cyclopropylmethyl)-1H-pyrazol-4-yl]-1H-benzimidazol-2-yl}amino)pyridin-4-yl]ethyl}piperazin-1-yl)-3,3,3-trifluoropropan-1-one
    参考文献:
    名称:
    Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor
    摘要:
    The serine/threonine kinase TBK1 (TANK-binding kinase 1) and its homologue IKK epsilon are noncanonical members of the inhibitor of the nuclear factor kappa B (I kappa B) kinase family. These kinases play important roles in multiple cellular pathways and, in particular, in inflammation. Herein, we describe our investigations on a family of benzimidazoles and the identification of the potent and highly selective TBK1/IKK epsilon inhibitor BAY-985. BAY-985 inhibits the cellular phosphorylation of interferon regulatory factor 3 and displays antiproliferative efficacy in the melanoma cell line SK-MEL-2 but showed only weak antitumor activity in the SK-MEL-2 human melanoma xenograft model.
    DOI:
    10.1021/acs.jmedchem.9b01460
点击查看最新优质反应信息

文献信息

  • Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor
    作者:Julien Lefranc、Volker Klaus Schulze、Roman Christian Hillig、Hans Briem、Florian Prinz、Anne Mengel、Tobias Heinrich、Jozsef Balint、Srinivasan Rengachari、Horst Irlbacher、Detlef Stöckigt、Ulf Bömer、Benjamin Bader、Stefan Nikolaus Gradl、Carl Friedrich Nising、Franz von Nussbaum、Dominik Mumberg、Daniel Panne、Antje Margret Wengner
    DOI:10.1021/acs.jmedchem.9b01460
    日期:2020.1.23
    The serine/threonine kinase TBK1 (TANK-binding kinase 1) and its homologue IKK epsilon are noncanonical members of the inhibitor of the nuclear factor kappa B (I kappa B) kinase family. These kinases play important roles in multiple cellular pathways and, in particular, in inflammation. Herein, we describe our investigations on a family of benzimidazoles and the identification of the potent and highly selective TBK1/IKK epsilon inhibitor BAY-985. BAY-985 inhibits the cellular phosphorylation of interferon regulatory factor 3 and displays antiproliferative efficacy in the melanoma cell line SK-MEL-2 but showed only weak antitumor activity in the SK-MEL-2 human melanoma xenograft model.
查看更多